Ivabradine for the Prevention of Anthracycline-Induced Cardiotoxicity in Female Patients with Primarily Breast Cancer: A Prospective, Randomized, Open-Label Clinical Trial

<i>Background and Objectives:</i> Cancer therapy containing anthracyclines is associated with cancer-treatment-related cardiac dysfunction and heart failure (HF). Conventional cardioprotective medications can be frequently complicated by their blood-pressure-lowering effect. Recently, elevated resti...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Eglė Čiburienė, Sigita Aidietienė, Greta Ščerbickaitė, Eglė Sadauskienė, Diana Sudavičienė, Edita Baltruškevičienė, Birutė Brasiūnienė, Monika Drobnienė, Jelena Čelutkienė
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	MDPI AG 2023-12-01
Seri Bilgileri:	Medicina
Konular:	cardio-oncology cancer-therapy-induced cardiotoxicity cardiotoxicity prevention
Online Erişim:	https://www.mdpi.com/1648-9144/59/12/2140
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!